mrh cv jan 31 2016

Marc. R. Hammerman, M.D.

1

CURRICULUM VITAE Name: Marc Randall Hammerman Permanent Address: 12 Shadow Creek Court Fairfax, California 94930 Contact Information: Tel: 415 578 2720 Email: [email protected] Date and Place of Birth: September 29, 1947 St. Louis, Missouri Citizenship: U.S.A. Marital Status: Married: Nancy Hammerman 8-9-74 Children: Seth (11-5-75); Megan (6-20-77) Education: University City High School, St. Louis County Missouri - May 1965 Washington University, St. Louis, Missouri - A.B. - August, 1969 Washington University School of Medicine, St. Louis, Missouri, - M.D. - May, 1972 Employment/Academic Affiliations/Hospital Appointments: July, 1972 - July, 1973 Medical Intern, Barnes Hospital, St. Louis, Missouri July, 1973 - July, 1974 1st Year Medical Resident, Barnes Hospital July, 1972- July, 1974 Assistant in Medicine, Washington University School of Medicine, St. Louis Missouri July, 1974 - July, 1976 Research Associate, Gerontology Research Center, National

Inst. on Aging, N.I.H., Baltimore, Maryland July, 1974 - July, 1976 Visiting Physician, Baltimore City Hospitals, Baltimore, Maryland

July, 1975 - July, 1976 Assistant in Medicine, Johns Hopkins University, Baltimore, Maryland

July, 1976 - July, 1977 Senior Medical Resident, Massachusetts General Hospital, Boston, Massachusetts

July, 1976 - July, 1977 Assistant in Medicine, Harvard Medical School, Boston, Massachusetts July, 1977 - July, 1978 Chief Medical Resident, Barnes Hospital, St. Louis, Missouri

Instructor in Medicine, Washington University School of Medicine, St. Louis, Missouri

Marc. R. Hammerman, M.D.

2

July, 1978 - July, 1979 Fellow in Metabolism and Endocrinology, Washington University, St. Louis, Missouri

July, 1979 - July, 1984 Assistant Professor of Medicine, Washington University School of Medicine, St. Louis, Missouri Assistant Physician, Barnes Hospital, St. Louis, Missouri

July, 1984 - July, 1989 Associate Professor of Medicine, Washington University School of Medicine, St. Louis, Missouri

July, 1984 - July, 1990 Associate Physician, Barnes Hospital, St. Louis, Missouri

July, 1985 – July 2015 Medical Staff Physician, The Jewish Hospital of St. Louis, Missouri July, 1989 – July 2015 Professor of Medicine, Washington University School of

Medicine, St. Louis, Missouri Associate Professor of Cell Biology and Physiology, Division of Biology and Biomedical Sciences

Physician, Barnes Hospital, St. Louis, Missouri February, 1992 - Chromalloy Professor of Renal Diseases in Medicine, Washington University School of Medicine July, 1996 – July 2015 Staff Physician, Barnes-Jewish Hospital, St. Louis, Missouri July, 2000 - July 2015 Professor of Cell Biology and Physiology, Washington

University School of Medicine Administrative Positions/Directorships: July, 1977 - July, 1978 Chief Medical Resident, Washington University School of

Medicine/Barnes Hospital, St. Louis, Missouri July, 1979 - Sept., 1980 Associate Director of House Staff Training Program,

Department of Medicine Washington University School of Medicine/Barnes Hospital, St. Louis, Missouri

Sept., 1980 - March, 1991 Director, of Housestaff Training Program (Postgraduate Medical Education) Department of Medicine Washington University School of Medicine/Barnes Hospital, St. Louis, Missouri

January, 1991 – July 2015 Director, Renal Division, Washington University School of Medicine, Barnes-Jewish Hospital, St. Louis, Missouri

April, 1997 – July 2015 Member, Board of Directors, BJC/Washington University School of Medicine Dialysis Network April, 1999 – July 2015 Medical Director, BJC/Washington University School of Medicine

Dialysis Network December 1999 – July 2005 Member, Board of Directors, Gambro/Washington University Healthcare of Greater St. Louis July, 2005 – July 2015 Member, Board of Directors, Davita/Washington University Healthcare of Greater St. Louis

Marc R. Hammerman, M.D.

3

Administrative Responsibilities: Committees: Member, Barnes Hospital Pharmacy and Therapeutics Committee 1977-1978 Member, Barnes Hospital Emergency Room Committee 1977-1991 Member, Washington U. Med School Committee on Academic Review and Promotions 1979-1987 Chair, Barnes Hospital/Washington University Intern Selection Committee 1979-1991 Member, Barnes Hospital Organ Transplantation Committee 1985-1991 Member, Washington University Technology Transfer Committee 1997-1998 Teaching: Coursemaster, Washington University CME Course, Gland Rounds, Endocrinology Review 1979 Coursemaster, Washington U. School of Med. Core Junior Internal Medicine Clerkship 1980-1991 Coursemaster, Washington University Sch. of Medicine Medicine Subinternship 1980-1991 Coursemaster, Washington University Sch. of Medicine Senior Nephrology Elective 1991- 1999 Clinical Responsibilities: Attending Physician Internal Medicine 1978 - 2015 Attending Physician Endocrinology and Metabolism 1979-1991 Honors: National Merit Finalist - 1965 University of Missouri Curators Award for High School Seniors - 1965 Phi Eta Sigma - 1966 Sophomore Honors Washington University - 1967 Phi Beta Kappa - 1968 Alpha Omega Alpha - 1971 Dr. Richard Brookings Prize, Washington University - 1972 Fellow, American College of Physicians - 1981 Established Investigator, American Heart Association - 1984 American Society for Clinical Investigation - 1985 MERIT Status, NIH Grant R37 DK27600 - 1988 Association of American Physicians - 1990 First Chromalloy Chair, Renal Diseases in Medicine, Washington University - 1992 Fellow, Molecular Medicine Society - 1996 Sigma Xi - 1999 Alumni Faculty Award, Washington University School of Medicine - 2002 Inaugural Fellow of the American Heart Association - 2003 Alumnus Honoree- Washington University Marc R. Hammerman Scholarship - 2005 University City High School Hall of Fame - 2007 Board Certification: National Board of Medical Examiners - 1973 American Board of Internal Medicine (58710) - 6-22-1977 American Board of Endocrinology and Metabolism (58710) - 6-19-1979


4

Licensure: Maryland D17509 1975-1982; Missouri R7960 1977-present; California G132610; 2014-present Military Service: U.S. Public Health Service 1971-76 Active Duty 1971-72; 1974-76; Permanent Rank at Discharge, Lieutenant Commander Honorable Discharge Professional Organizations: American Association for the Advancement of Science American College of Physicians American Federation for Medical Research American Heart Association American Physiological Society American Society for Clinical Investigation American Society of Nephrology American Society of Transplantation Association of American Physicians The Endocrine Society International Society of Nephrology National Kidney Foundation Professional Associations and Societies: Harvard Medical Alumni Association Associate Joseph Erlanger Faculty/Student Society, Washington University 1986-1992 (founding member) Missouri State Medical Association St. Louis Metropolitan Medical Society Other Professional Activities: Advisory/Consultative: American Heart Association, Scientific Council Kidney July, 1984- Councilor Midwest Section, American Federation for Clinical Research, July, 1985 - July, 1988 National Kidney Foundation of Eastern Missouri- Board of Directors 1991-1993 Genentech Inc., Consultant in Renal Dysfunction April, 1992-April, 1996 Millennium Biotherapeutics Inc., Consultant in Renal Disease August, 1999- August 2000 Intercytex Ltd., Scientific Advisory Board April 2000 - January 2002 Solving Organ Shortage, Executive Board November 2014 - July 2015


5

Scientific/Review: Cardiovascular A-II Research Committee, American Heart Association, July, 1986 - July, 1990 Research Fellowship Committee a, American Heart Association July, 1990 - July, 1993 NIH General Medicine B Study Section, Special Reviewer, July, 1990, March 1992 NIH NIDDK Special Grants Review Committee (Subcommittee D), July, 1990 - July, 1993, Chairman, July 1993-July 1995. NIH ALTX 4 Study Section, Special Reviewer July, 1998 NIH NIDDK Stem Cell and Developmental Biology Writing Group Prostate, Bladder and Kidney

Stem Cells, 2001 European Union Commission Sixth Framework Program functional genomics, 2003 Editorial:

American Journal of Physiology, Renal, Fluid, and Electrolyte Physiology: Editorial Board, July, 1985 - July 1995; July 2001- July 2015

Associate Editor, July, 1989 - July 1995 Current Opinion in Nephrology and Hypertension: Section Editor, Hormones, Autacoids, Neurotransmitters and Growth Factors, 1997-2004 Current Opinion in Organ Transplantation: Section Editor, Organogenesis and Organ Regeneration and Repair, 2013-2015 Journal of the American Society of Nephrology: Editorial Board, July 1996 - December 1997 Kidney International: Deputy Editor, January 1998 - December 2005 Transplant Immunology Section Editor: Organogenesis, January 2005 –July 2010 Organogenesis Editorial Board, July 2004 – July 2013 Editor for Organogenesis Forum July 2007- July 2013


6

Grants and Awards as PI: Training Grants: Principal Investigator Renal Diseases NIH-NIDDK T32 DK07126 1 January 1991 - 30 June 2015 Minority Supplements: 2000-2005; 2006-07 Fellowship: Awardee Institutional National Research Service Award Diabetes and Related Metabolic Diseases (W.H. Daughaday, P.I.) NIH T32 AM07120 1 July, 1978 - 30 June, 1979 Institutional based: Project Director Renal Membrane Phosphorylation and Transport Biomedical Research Support Grant (S. Kornfeld, P.I.) NIH SO7 RR05389 1 July, 1979 - 30 June, 1980 Project Director Insulin Effects on Renal Membrane Phosphorylation and Transport Diabetes Research and Training Center (W.H. Daughaday, P.I.) NIH-NIDDK P60 AM20579 1 December, 1984 - 30 November, 1985 Project Director IGF I in Renal Insufficiency Washington University GCRG (W. Peck, P.I.) NIH-NIDDK M01RR000036-361150-391150 I July 1995- 30 June 1999 Investigator initiated: Principal Investigator Renal Growth NIH-NIDDK R01 DK27600 1 July, 1980 - 30 June, 1988 NIH-NIDDK R37 DK27600 1 July, 1988 - 30 June, 1996 (MERIT Status Awarded) Principal Investigator Insulin and IGF Action on Membrane Phosphoinositides Juvenile Diabetes Foundation 186270 1 September, 1986 - 30 August, 1990


7

Principal Investigator Insulin-like Growth Factors and Kidney Development NIH-NIDDK R01 DK42958 1 July, 1990 - 30 April, 1992 Principal Investigator Actions of Growth Hormone and IGF I on Renal Function American Heart Association Grant-in-aid Number 91006660 1 July, 1991 - 30 June, 1994 Principal Investigator Renal Growth Factor Networks in Diabetes Mellitus Juvenile Diabetes Foundation Grant 191541 1 September 1991- 30 August 1993 Principal Investigator Use of IGF I in Chronic Renal Failure Research Grant and Supply Agreement Genentech Inc. S. San Francisco CA 1 March 1992- 1 February 1995 Principal Investigator IGF I in Acute Renal Failure Research Grant and Supply Agreement Genentech Inc. S. San Francisco CA 1 March 1994- 30 November 1995 Principal Investigator Renal Growth Factors Diabetes Research & Wellness Foundation 1 January 2003 - 31 December 2003 Principal Investigator Novel Renal Gene Expression in Acute Renal Failure Bayer Corporation 1 December 1996- 30 November 1998 Principal Investigator Growth Factors in Acute Renal Failure Biogen Incorporated 1 May 1997- 30 December 1997 Principal Investigator Chimeric Pig Kidney Intercytex Ltd. UK 1 January 2000 - 30 April 2002


8

Principal Investigator Chimeric Kidney NIH-NIDDK R01 DK053497 1 August, 1998 - 30 June, 2002 Principal Investigator Chimeric Kidney NIH-NIDDK R21 DK063379 1 July 2002- 30 June, 2004 Principal Investigator Pig to Primate Xenotransplantation of Pancreatic Anlagen Juvenile Diabetes Research Foundation 1-2005-110 1 April 2005- 31 March 2008 Principal Investigator Growing a new endocrine pancreas Juvenile Diabetes Research Foundation 1-2008-37 1 March 2008- 28 February 2011 Center Grants: Project Director Renal Glucose Homeostasis in Health and Disease Pathophysiology of Renal Disease and Uremia (S. Klahr, P.I.) NIH-NIDDK P01 DK09976 1 September, 1988 - 30 August, 1991 Principal Investigator Renal Genes, Growth Factors, Development and Disease George M. O'Brien Kidney and Urological Diseases Center NIH-NIDDK P50 DK45181 1 May, 1992 - 30 April 2003 Project Director: Polypeptide Growth Factors and Renal Development Project Director: Administrative Core Project Director: Organ Culture and Tissue Processing Core Principal Investigator Washington University Center for Kidney Disease Research George M. O'Brien Kidney and Urological Diseases Center NIH-NIDDK P30 DK079333 ARRA Supplement 11 August 2009 – 10 August 2011 Principal Investigator Washington University Center for Kidney Disease Research George M. O'Brien Kidney and Urological Diseases Center NIH-NIDDK P30 DK079333 1 August, 2007 - 31 May 2013 Core Director: Renal Organogenesis Core


9

Other Academic/Professional Support: Academic Scholarship Washington University 1965-1968 Academic Scholarship Washington University School of Medicine 1968-1971 United States Public Health Service Commissioned Officers Student Training and Externship Program (active duty status) 1971-1972 Established Investigatorship, American Heart Association 1 July, 1984 - 30 June, 1989


10

Major Invited Lectures: Gordon Conference, Biochemistry and Physiology of Bones and Teeth Meriden, New Hampshire, July 1982 Regulation of phosphate transport in kidney by growth hormone and parathyroid hormone American Physiological Society, Conference on Hydrogen Ion Transport in Epithelia Honolulu, Hawaii, August, 1983 Regulation of Na+-H+ exchange in kidney: acidosis and compensatory growth Second International Workshop on Calcium and Phosphate Transport Across Biomembranes Vienna, Austria, March, 1984 Phosphate transport in the kidney, studies with isolated membrane vesicles 68th Annual Meeting of Federation of American Societies for Experimental Biology St. Louis, MO, April 1984 Regulation of renal phosphate reabsorption National Kidney Foundation Conference on Growth in Children with Renal Diseases Warrenton, VA, May 1985 Regulation of renal phosphate transport in the setting of reduced functional renal mass International Society of Nephrology Conference on Molecular Biology and the Kidney Pinehurst, NC, September, 1986 Hormone-receptor interactions in kidney; and Calcium signaling in kidney 72nd Annual Meeting of Federation of American Societies for Experimental Biology Las Vegas, NV, May 1988 Growth factors in kidney International Society of Nephrology Conference on Signal Transduction Chatham MA, October 1988 Growth factor expression in kidney 21st Annual Meeting of the American Society of Nephrology San Antonio TX, December 1988, Insulin-like growth factor I and the kidney 1st International Workshop on Patterns of Renal Growth, Royal College of Physicians London UK, September 1989 Expression of IGF I in kidney International Symposium on Growth in Children with Chronic Renal Failure Heidelberg FRG, April, 1990 Actions of IGF I in kidney


11

11th International Congress of Nephrology Tokyo Japan, July 1990 Growth hormone, IGF I and kidney 23rd Annual Meeting of American Society of Nephrology Washington DC, December 1990 Roles of IGF I in renal function and development 14th International Diabetes Federation Congress Washington DC, June 1991 Expression of IGF I in adult kidney and in developing kidney 4th International Workshop on Growth, and Metabolic Aspects of Growth Hormone Copenhagen, Denmark, October, 1991 Growth hormone and kidney 6th International Conference in Renal Nutrition and Metabolism Harrogate UK, August 1991 Roles of growth factors in kidney growth and development 5th International Workshop on Developmental Renal Physiology Tremezzo, Italy, August, 1992 Growth factors and metanephrogenesis New York Nephrological Society New York, NY, April 1993 Amazing tales of giants and dwarfs 12th International Congress of Nephrology Jerusalem Israel, June 1993 Potential therapeutic role for IGF I in chronic renal failure Contemporary Issues in Nephrology- Continuing Medical Education Course Brigham and Womens Hospital, Harvard Medical School Boston MA, October, 1993 Growth factors and kidney-therapeutic implications 43rd Annual Meeting of National Kidney Foundation Boston MA, November 1993 Growth factors in acute renal failure 27th Annual Meeting of American Society of Nephrology Boston MA, November 1993 IGF I in chronic renal failure 28th Meeting of the European Society of Pediatric Nephrology Amsterdam, Netherlands, September 1994 Therapeutic role for IGF I in chronic renal failure-clinical trials


12

6th Congress on Nephrotoxicity and Nephrocarcinogenicity Noordwijkerhout, Netherlands, September 1994 Growth factors in acute renal failure and renal development 28th Annual Meeting of American Society of Nephrology Orlando FL, October 1994 New therapeutic options, growth factors and acute renal failure International Symposium on Growth and Endocrine Changes in Kidney Disease Heidelberg Germany, March 1995 Therapeutic roles for IGF I in acute and chronic renal failure Wenner-Gren Foundation Meeting on the Biology of the Epithelial Cell Stockholm Sweden, May 1995 Fulminant metanephric apoptosis and abnormal kidney development in the bcl-2-/- mouse 13th International Congress of Nephrology Madrid Spain, July 1995 Growth factors and kidney development 6th International Workshop on Developmental Renal Physiology Warrenton VA, August 1995 Growth factors and metanephrogenesis Annual Kidney Research Aid Fund Lecture Institute of Child Health and Great Ormond Street Hospital University College London London, UK, March 1996 Use of growth factors to modulate acute and chronic renal disease 80th Annual Meeting of Federation of American Societies of Experimental Biology Washington DC, April 1996 Cellular effects of growth hormone in the kidney American Society for Pediatric Nephrology Washington DC May 1996 Is Progression Inevitable in Pediatric Chronic Renal Insufficiency? - Therapeutic Intervention National Institutes of Health Conference, Acute Renal Failure in the 21st Century Co-Chairperson, Washington D.C.May 1996 Mead Johnson Symposium in Perinatal and Developmental Medicine Aspen Colorado, June 1996 Role of growth factors in kidney growth and regeneration following acute renal failure & Growth factor gene expression in kidney development 10th Annual Investigators Meeting of the National Cooperative Growth Study San Francisco CA, October 1996 The effects of growth hormone and IGF I on renal growth and function


13

Symposium on Intensive Care Nephrology, Technische Universitat Dresden Dresden Germany, May 1997 New approaches to the treatment and prevention of acute renal failure- The potential role of growth factors Tripartite Renal Meeting University College London London UK, May 1997 Metanephrogenesis: From bench to bedside 30th Annual Meeting, American Society of Nephrology Advances in Basic Science Conference Mechanisms of Epithelial Tissue Injury, Repair and Regeneration, San Antonio, Texas, November 1997 Growth factors and apoptosis in renal ischemia FASEB Summer Research Conference, Renal Hemodynamics Saxtons River, Vermont, June

1998 Role of growth factors in kidney maturation New York Nephrological Society New York, NY, October 1998 New developments in experimental renal therapeutics Kidney International Nephrology Forum Boston MA, June 1999 Utility in nephrology for recapitulation of phylogeny by ontogeny 32nd Annual Meeting, American Society of Nephrology Advances in Basic Science Conference New Horizons in Vascular Biology and Therapy Miami, Florida, November 1999 Modeling and defining tissue vasculature: new developments in kidney development

Society of Toxicology: Mechanisms of Nephrotoxicity Nephrocarcinogenicity

Marthas Vineyard MA, April 2000 Growing kidneys: Sometimes ignorance is bliss Scandinavian Society of Nephrology, Odense Denmark, May 2001 How to grow a kidney 38th European Renal Association/European Dialysis and Transplant Association Congress, Vienna Austria, June 2001 Renal replacement therapies of the future 11th International Congress of Immunology, Stockholm, Sweden, July 2001 Transplantation of embryonic kidneys


14

FASEB Summer Research Conference, Growth factor, receptor tyrosine kinases in mitogenesis,

morphogenesis, and tumorigenesis Snowmass Village CO, August 2001 Growing New Kidneys & IGF I therapy for renal disease

1st Intl Conference on Xenotransplantation of Cells Tissues & Organs from Pig to Man Turin Italy, March 2002 Transplantation of Pig Renal Precursor Cells 2nd International Engineering Tissue Growth Conference Pittsburgh PA, March 2002 Growing kidneys 48th International Society of Artificial Internal Organs New York, New York, June 2002 Growing New Kidneys 7th Annual Winter Symposium of the American Society for Transplantation Naples, Florida, February 2003 Function and Potential for Renal Organogenesis & What is the Future of Kidney Replacement? 47th Meeting of the Japanese Society of Nephrology Utsunomiya Tochigi JAPAN May 2004 Growing New Organs in Situ

5th Annual American Transplant Congress Boston, Massachusetts, May 2004 Kidney Regeneration

International Society of Nephrology Forefronts in Nephrology Vascular repair and regulation in kidney disease Dresden, Germany, October 2004 Cellular transplantation of nephrons 37th Annual Meeting, American Society of Nephrology St. Louis Missouri, November 2004 Frontiers in Renal Transplantation - Renal Organogenesis International Society of Nephrology Forefronts in Nephrology Stem cells and regeneration of the kidney Karuizawa Nagano JAPAN, January 2005 Organogenesis of kidneys following transplantation of renal progenitor cells


15

4th Annual Congress, Japanese Society for Regenerative Medicine Osaka JAPAN, March 2005 Organogenesis: Growing New Organs in Situ 23rd Annual Meeting of the International Society of Blood Purification Rotterdam, The Netherlands, September 2005 Tissue Engineering and the Kidney 3rd Renal Transplantation Symposium University of Pavia Pavia Italy, September 2005 Renal Organogenesis from Transplanted Metanephric Primordia 12th Congress of the European Society for Organ Transplantation Geneva Switzerland, October 2005 Transplantation of Embryonic Organs – Kidney and Pancreas Berliner Dialyseseminar 2005 Berlin Germany, December 2005 New Aspects of Renal Transplantation - Organogenesis 31st Annual Meeting NATCO/American Society of Transplantation Symposium Chicago IL, August 2006 Growing Kidneys Brazilian Congress of Nephrology 2006 Gramado Brazil, October 2006 Organogenesis of Kidney & Pancreas Experimental Biology 2007 Washington DC, April 2007 Growing New Kidney & Endocrine Pancreas 53rd International Society of Artificial Internal Organs Chicago IL, June 2007 Organogenesis of Kidney & Endocrine Pancreas Finnish Society of Developmental Biology Oulu Finland, August 2007 Growing New Organs in situ Philadelphia Endocrine Society Philadelphia PA, November 2011 Organogenesis of the Endocrine Pancreas Buck Institute on Aging Novato California, May 2015 Age-related Kidney Disease and the New Age of Kidney Regeneration


16

Other Invited Lectures: Sinai Hospital, Johns Hopkins University, Baltimore MD, Dept.of Medicine, October 1981 Laboratory of Molecular Aging, National Institutes of Health, Baltimore, MD, December 1983 Laboratory of Molecular Aging, National Institutes of Health, Baltimore, MD, April 1984 University of California Los Angeles School of Medicine, Renal Division, April 1985 Cornell University Medical College, Renal Division, New York, NY, May 1985 Duke University School of Medicine, Endocrine Division, Durham NC, July 1986 University of Iowa School of Medicine, Endocrine Division, Iowa City IA, March 1987 University of Illinois, Champaign-Urbana, Biochemistry Department, July 1987 University of Wisconsin School of Medicine, Endocrine Division, Madison WI, January 1988 University of Texas Health Science Center, Renal Division, Houston TX, March 1988 St. Louis University, St. Louis MO, Biochemistry Department, July 1988 University of Michigan, Ann Arbor, Physiology Department, October 1988 National Cancer Institute, National Institutes of Health, Frederick MD, October 1988 SUNY Stony Brook Health Science Center, Renal Division, Stony Brook NY, November 1988 University of Wisconsin School of Medicine, Renal Division, Madison WI, February 1989 Smith-Kline Beecham, Philadelphia PA, February 1989 Monsanto-Searle, St. Louis MO, March 1989 University of California Los Angeles School of Medicine, Renal Division, July 1989 Genentech Incorporated, South San Francisco CA, February 1990 University of Kentucky Sch. Of Med., Lexington KY, Department of Medicine, February 1990 Duke University School of Medicine, Department of Medicine, Durham NC, May 1990 Duke University School of Medicine, Renal Division, Durham NC, November 1991 Genentech Incorporated, South San Francisco CA, February 1992 Genentech Incorporated, South San Francisco CA, October 1992 Stanford University School of Medicine, Renal Division, Palo Alto CA, October 1992 University of Iowa School of Medicine, Renal Division, Iowa City IA, January 1993 University of Texas, Health Science Center, San Antonio TX, Renal Division, February 1993 University of Maryland School of Medicine, Renal Division, Baltimore MD, March 1993 SUNY Stony Brook Health Science Center, Dept. of Medicine, Stony Brook NY, April 1993 Albert Einstein College of Medicine, Renal Division, New York NY, April 1993 Genentech Incorporated, South San Francisco CA, August 1993 Iowa State University, Biochemistry Department, Ames Iowa, August 1993 Tulane University School of Medicine, Renal Division, New Orleans LA, December 1993 University of Missouri, Pharmacology Department, Columbia MO, March 1994 Genentech Incorporated, South San Francisco CA, October 1994 Biogen Incorporated, Boston MA, December 1994 Merck Research Laboratories, Rathway NJ, December, 1994 Miles Pharmaceuticals, West Haven Connecticut, January 1995 University of Florida School of Medicine, Renal Division, Gainesville FL, March 1995 Genentech Incorporated, South San Francisco CA, March 1995 Columbia College of Physicians & Surgeons, Renal Division, New York, NY, April, 1995 Beth Israel Hosp., Albert Einstein College of Med., Renal Division, New York, NY, April, 1995 Vanderbilt University School of Medicine, Renal Division, Nashville TN, May 1995 Genentech Incorporated, South San Francisco CA, July 1995 Monsanto-Searle, St. Louis MO, February, 1996 Leicester General Hospital, Renal Division, Leicester United Kingdom, March 1996


17

Biogen Incorporated, Boston MA, March 1996 Creative Biomolecules, Boston MA, March 1996 Boston University School of Medicine, Renal Division, Boston MA, October 1996 SUNY Syracuse Health Science Center, Renal Division, Syracuse NY, November 1996 IDUN Pharmaceuticals, San Diego CA, December 1996 University of Texas Health Sci.Center, Dept of Medicine, San Antonio TX, February, 1997 Polycystic Kidney Disease Research Foundation, St. Louis MO Chapter, September 1997 University of Maryland School of Medicine, Renal Division, Baltimore MD, September 1997 University of Pennsylvania School of Medicine, Renal Division, Philadelphia PA, October 1997 Bayer Pharmaceuticals, Biotechnology, Berkeley CA, October 1997 SUNY Stony Brook Health Science Center, Renal Division, Stony Brook NY, October, 1998 Albert Einstein College of Medicine, Pediatric Renal Division, New York NY, October 1998 Biotransplant Incorporated, Charlestown MA, December 1998 Diacrin Incorporated, Charlestown MA, December 1998 Tufts University School of Medicine, Renal Division, Boston MA, June 1999 Millennium Biotherapeutics Inc, Cambridge MA, August 1999 Intercytex Ltd, Manchester UK, April, 2000 Millennium Biotherapeutics Inc, Cambridge MA, June 2000 Chiron Corporation, Emeryville CA, August 2000 Intercytex Ltd., Lexington MA, May 2001 Diacrin Incorporated, Charlestown MA, May 2001 University of Sheffield UK, Renal Division, December 2001 Intercytex Ltd., Manchester UK, December 2001

University of Cincinnati Childrens Hosp. Res. Foundation Devel. Biology, January 2002 William Beaumont Hosp, Wayne State University, Dept of Med, Royal Oak MI, August 2002 Duke University School of Medicine, Renal Division, Durham NC, September 2002 New York Medical College, Department of Medicine, New York, NY, October 2002 Brigham & Womens Hospital. Harvard Med. School, Renal Division Boston MA, February 2004 Revivicor Inc., Blacksburg VA, August 2004

St. Louis Regional Chamber & Growth Assoc. TechConnect 2004, St. Louis MO, October 2004 University of Indiana, Renal Division Indianapolis IN, November 2004 University of Maryland, Renal Division Baltimore MD, April 2005 BioTime Inc. Emeryville CA, August 2005 Albert Einstein Medical Center, Thomas Jefferson Med. Col. Philadelphia PA, November 2005 Genentech Incorporated & Tercica Inc., South San Francisco CA, August 2006 Vanderbilt University School of Medicine, Renal Division, Nashville TN, December 2006 University of Kansas Medical Center, Department of Anatomy, Kansas City KS, April 2009 BioTime Inc. Alameda CA, July 2014


18

Original Research Publications: 1. Weinberg, W., Penick, E., Hammerman, M. and Jackoway, M. The influence of a summer remedial reading program upon the development of reading: A preliminary report Am. J. Dis. of Children 122:494-498, 1971. 2. Fass, S.J., Hammerman, M.R., and Sacktor, B. Transport of amino acids in renal brush border

membrane vesicles. Uptake of the neutral amino acid L-alanine. J. Biol. Chem. 252:583-590, 1977.

3. Hammerman, M.R., and Sacktor, B. Transport of amino acids in renal brush border membrane

vesicles. Uptake of L-proline. J. Biol. Chem. 252:591-595, 1977. 4. Hammerman, M.R., and Sacktor, B. Transport of beta-alanine in renal brush border membrane

vesicles. Biochim. Biophys. Acta 509:338-347, 1978. 5. Hammerman, M.R., Sacktor, B., and Daughaday, W.H. Myo-inositol transport in renal brush

border vesicles and its inhibition by glucose. Am. J. Physiol. 239:F113-F120, 1980. 6. Schneider, E.G., Hammerman, M.R., and Sacktor, B. Sodium gradient-dependent L-glutamine

transport in renal brush border membrane vesicles: evidence for an electroneutral mechanism. J. Biol. Chem. 255:7650-7656, 1980.

7. Hammerman, M.R., Karl, I.E., and Hruska, K.A. Regulation of canine renal vesicle Pi transport by

growth hormone and parathyroid hormone. Biochim. Biophys. Acta 603:322-335, 1980. 8. Hruska, K.A. and Hammerman, M.R. Parathyroid hormone inhibition of phosphate transport in

renal brush border vesicles from phosphate depleted dogs. Biochim. Biophys. Acta 645:351-356, 1981.

9. Hruska, K.A., Klahr, S., and Hammerman, M.R. Decreased luminal membrane transport of

phosphate in chronic renal failure. Am. J. Physiol. 242:F17-F22, 1982. 10. Hammerman, M.R., and Hruska, K.A. Cyclic AMP dependent protein phosphorylation in canine

renal brush border membrane vesicles is associated with decreased phosphate transport. J. Biol. Chem. 257:992-999, 1982.

11. Hammerman, M.R. Na+-independent L-arginine transport in rabbit renal brush border membrane

vesicles. Biochim. Biophys. Acta 685:71-77, 1982. 12. Hammerman, M.R., and Sacktor, B., Na+-dependent transport of glycine in renal brush border

membrane vesicles, evidence for a single specific transport system. Biochim. Biophys. Acta 686:189-196, 1982.

13. Weinreb, S., Hruska, K.A., Klahr, S., and Hammerman, M.R. Uptake of Pi in brush border

vesicles after release of unilateral ureteral obstruction. Am. J. Physiol. 243:F29-F35, 1982.


19

14. Cohn, D.E., Hruska, K.A., Klahr, S., and Hammerman, M.R. Increased Na+/H+ exchange in brush border vesicles from dogs with renal failure. Am. J. Physiol. 243:F293-F299, 1982.

15. Hammerman, M.R., Hansen, V., and Morrissey, J.J. ADP-ribosylation of canine renal brush

border membrane vesicle proteins is associated with decreased phosphate transport. J. Biol. Chem. 257:12380-12386, 1982.

16. Hammerman, M.R., Hansen, V., and Morrissey, J.J. Cyclic AMP-dependent protein

phosphorylation and dephosphorylation alter phosphate transport in canine renal brush border vesicles. Biochim. Biophys. Acta 755:10-16, 1983.

17. Hruska, K.A., Mills, S.C., Khalifa, S., and Hammerman, M.R. Phosphorylation of Renal Brush

Border Membrane Vesicles. Effect on calcium uptake and membrane content of polyphosphoinositides. J. Biol. Chem. 258:2501-2507, 1983.

18. Cohn, D.E., Klahr, S., and Hammerman, M.R. Metabolic acidosis and parathyroidectomy

increase Na+-H+ exchange in brush border vesicles. Am. J. Physiol. 245:F217-F222, 1983. 19. Hammerman, M.R., Corpus, V.M., and Morrissey, J.J. NAD+-induced inhibition of phosphate

transport in canine renal brush border membranes - mediation through a process other than or in addition to NAD+ hydrolysis. Biochim. Biophys. Acta 732:110-116, 1983.

20. Hammerman, M.R., and Chase, L.R. Pi transport, phosphorylation and dephosphorylation in

renal membranes from HYP/Y mice. Am J. Physiol. 245:F701-F706, 1983. 21. Hammerman, M.R., Cohn, D.E., Tamayo, J., and Martin, K.J. Effect of parathyroid hormone on

Na+-dependent phosphate transport and cAMP-dependent 32P-phosphorylation in brush border vesicles from isolated perfused canine kidneys. Arch. Biochem. Biophys. 227:91-97, 1983.

22. Windus, D., Cohn, D.E., Klahr, S., and Hammerman, M.R. Glutamine transport in renal

basolateral vesicles from dogs with metabolic acidosis. Am. J. Physiol. 246:F78-F86, 1984. 23. Schwab, S.J., Klahr, S., and Hammerman, M.R. Na+-gradient dependent Pi uptake in basolateral

membrane vesicles from dog kidney. Am. J. Physiol. 246:F663-F669, 1984. 24. Windus, D.W., Klahr, S., and Hammerman, M.R. Glutamine transport in basolateral vesicles from

dogs with acute respiratory acidosis. Am. J. Physiol. 247:F403-F407, 1984. 25. Hammerman, M.R., and Gavin, J.R., III, Insulin-stimulated phosphorylation and insulin binding in

canine renal basolateral membranes. Am. J. Physiol. 247:F408-F417, 1984. 26. Schwab, S.J., Klahr, S., and Hammerman, M.R. Uptake of Pi in basolateral vesicles after release

of unilateral ureteral obstruction. Am. J. Physiol. 247:F543-F547, 1984. 27. Hammerman, M.R., Rogers, S., Hansen, V.A., and Gavin, J.R., III. Insulin stimulated Pi transport

in brush border vesicles from proximal tubular segments. Am. J. Physiol. 247:E616-E624, 1984.


20

28. Hammerman, M.R., and Gavin, J.R., III. Binding of IGF II and multiplication stimulating activity-stimulated phosphorylation in basolateral membranes from dog kidneys. J. Biol. Chem. 259:13511-13517, 1984.

29. Rogers, S., Gavin, J.R., III, and Hammerman, M.R. Phorbol esters inhibit gluconeogenesis in

canine renal proximal tubular segments. Am. J. Physiol. 249:F256-F262, 1985. 30. Schwab, S.J., and Hammerman, M.R. Na+-gradient-dependent glycine uptake in basolateral

membrane vesicles from dog kidney. Am. J. Physiol. 249:F338-F345, 1985. 31. Schwab, S.J., and Hammerman, M.R. Electrogenic Na+-independent Pi transport in canine renal

basolateral membrane vesicles. Am J. Physiol. 250:F419-F424, 1986. 32. Mellas, J., and Hammerman, M.R. Phorbol ester-induced alkalinization of canine renal proximal

tubular cells. Am. J. Physiol. 250:F451-F459, 1986. 33. Hammerman, M.R. Phosphorylation of type II cAMP-dependent protein kinase in renal brush

border membranes. Am. J. Physiol. 250:F659-F666, 1986. 34. Hammerman, M.R., Rogers, S., Morrissey, J.J., and Gavin, J.R., III. Phorbol ester-stimulated

phosphorylation of basolateral membranes from canine kidney. Am J. Physiol. 250:F1073-F1081, 1986.

35. Hammerman, M.R., and Gavin, J.R., III. Binding of IGF I and IGF I-stimulated phosphorylation in

canine renal basolateral membranes. Am. J. Physiol. 251:E32-E41, 1986. 36. Levy, J., Gavin, J.R., III, Hammerman, M.R., and Avioli, L.V. Ca2++Mg2+ ATPase activity in kidney

basolateral membrane in non-insulin-dependent diabetic rats. Diabetes 35:899-905, 1986. 37. Mellas, J., Gavin, J.R., III, and Hammerman, M.R. Multiplication-stimulating activity induced

alkalinization of canine renal proximal tubular cells. J. Biol. Chem. 261:14437-14442, 1986. 38. Levy, J.R., Gavin, J.R., III, Morimoto, S., Hammerman, M.R., and Avioli, L.V. Hormonal regulation

of (Ca2++Mg2+) ATPase activity in canine renal basolateral membrane. Endocrinology 119:2405-2411, 1986.

39. Rogers, S., and Hammerman, M.R. Calcium-activated phospholipase C associated with canine

renal basolateral membranes. Am. J. Physiol. 252:F74-F82, 1987. 40. Chobanian, M.C., and Hammerman, M.R. Phorbol esters inhibit ammoniagenesis and

gluconeogenesis in proximal tubular segments. Am. J. Physiol. 252:F1073-F1079, 1987. 41. Hammerman, M.R., and Rogers, S. Distribution of IGF receptors in the plasma membrane of the

proximal tubular cell. Am. J. Physiol. 253:F841-F847, 1987. 42. Chobanian, M.C., and Hammerman, M.R. Insulin stimulates ammoniagenesis in canine renal

proximal tubular segments. Am J. Physiol. 253:F1171-F1177, 1987.


21

43. Cheung, P., and Hammerman, M.R. Na+-independent D-glucose transport in rabbit renal basolateral membranes. Am. J. Physiol. 254:F711-F718, 1988.

44. Rogers, S.A., and Hammerman, M.R. Insulin-like growth factor II stimulates production of inositol

trisphosphate in proximal tubular basolateral membranes from dog kidney. Proc. Natl. Acad. Sci. USA 85:4037-4041, 1988.

45. Bortz, J.D., Rotwein, P.S., DeVol, D., Bechtel, P.J., Hansen, V.A., and Hammerman, M.R. Focal

expression of insulin-like growth factor I in rat kidney collecting duct. J. Cell. Biol. 107:811-819, 1988.

46. Chobanian, M.C., and Hammerman, M.R. Parathyroid hormone stimulates ammoniagenesis in

canine renal proximal tubular segments. Am. J. Physiol. 255:F847-F852, 1988. 47. Rogers, S.A., and Hammerman, M.R. Mannose-6-phosphate potentiates IGF II-stimulated

inositol trisphosphate production in proximal tubular basolateral membranes. J. Biol. Chem. 264:4273-4276, 1989.

48. Cheung, P.T., and Hammerman, M.R. Cytochalasin B binding to rabbit proximal tubular

basolateral membranes. Kidney International. 35:1290-1294, 1989. 49. Lajara, R., Rotwein, P., Bortz, J.D., Hansen, V.A., Sadow, J.L., Betts, C.R., Rogers, S.A., and

Hammerman, M.R. Dual regulation of insulin-like growth factor I expression during renal hypertrophy. Am. J. Physiol. 257:F252-F261, 1989.

50. Rogers, S.A., and Hammerman, M.R. Growth hormone activates phospholipase C in proximal

tubular basolateral membranes from canine kidney. Proc. Natl. Acad. Sci. USA 86:6363-6366, 1989.

51. Rogers, S.A., Karl, I.E., and Hammerman, M.R. Growth hormone directly stimulates

gluconeogenesis in canine renal proximal tubule. Am. J. Physiol. 257:E751-E756, 1989. 52. Rogers, S.A., Purchio, A.F., and Hammerman, M.R. Mannose 6-phosphate-containing peptides

activate phospholipase C in proximal tubular basolateral membranes from canine kidney. J. Biol. Chem. 265:9722-9727, 1990.

53. Miller, S.B., Rotwein, P., Bortz, J.D., Bechtel, P.J., Hansen, V.A., Rogers, S.A., and Hammerman,

M.R. Renal expression of IGF I in hypersomatotropic states. Am. J. Physiol. 259:F251-F257, 1990.

54. Rogers, S.A., Miller, S.A., and Hammerman, M.R. Growth hormone stimulates IGF I gene

expression in isolated rat renal collecting duct. Am. J. Physiol. 259:F474-F479, 1990. 55. Miller, S.B., Hansen, V.A., and Hammerman, M.R. Effects of growth hormone and IGF I on renal

function in rats with normal and reduced renal mass. Am. J. Physiol. 259:F747-F751, 1990.


22

56. Rogers, S.A., Miller, S.B., and Hammerman, M.R. IGF I gene expression in isolated rat renal collecting duct is stimulated by epidermal growth factor. J. Clin. Invest. 87:347-351, 1991.

57. Rogers, S.A., Ryan, G., and Hammerman, M.R. Insulin-like growth factors I and II are produced

in the metanephros and are required for growth and development in vitro. J. Cell. Biol. 113:1447-1454, 1991.

58. Rogers, S.A., Ryan, G., and Hammerman, M.R. Metanephric transforming growth factor- is required for renal organogenesis in vitro. Am. J. Physiol. 262:F533-F539, 1992. 59. Miller, S.B., Rogers, S.A., Estes, C.E. and Hammerman, M.R. Increased distal nephron EGF content and altered distribution of peptide in compensatory renal hypertrophy. Am. J. Physiol. 262:F1032-F1038, 1992. 60. Miller, S.B., Martin, D.R., Kissane, J., and Hammerman, M.R. Insulin-like growth factor I accelerates recovery from acute tubular necrosis in the rat. Proc. Natl. Acad. Sci. USA 89:11876-11880, 1992. 61. Rogers, S.A. and Hammerman, M.R. Epidermal growth factor binding and stimulation of inositol trisphosphate production in basolateral membranes from dog kidney. Biochem. Biophys. Res. Communications 191:1319-1325, 1993. 62. O'Shea, M., Miller, S.B., and Hammerman, M.R. Effects of IGF I on renal function in patients with chronic renal failure. Am. J. Physiol. 264:F917-F922, 1993. 63. Rogers, S.A., Miller, S.B., and Hammerman, M.R. Enhanced renal IGF I expression following partial kidney infarction. Am. J. Physiol. 264:F963-F967, 1993. 64. Rogers, S.A., Ryan, G., Purchio, A.F. and Hammerman, M.R. Metanephric transforming growth

factor ß1 regulates nephrogenesis in vitro. Am. J. Physiol. 264: F996-F1002, 1993. 65. Miller, S.B., Martin, D.R., Kissane, J. and Hammerman, M.R. Hepatocyte growth factor accelerates recovery from acute ischemic renal injury in rats. Am. J. Physiol. 266: F129-F134, 1994. 66. Miller, S.B., Martin, D.R., Kissane, J. and Hammerman, M.R. Rat models for the clinical use of insulin-like growth factor I in acute renal failure. Am. J. Physiol. 266:F949-F956, 1994. 67. Miller, S.B., Moulton, M., O'Shea, M. and Hammerman, M.R. Effects of IGF I on renal function in end-stage chronic renal failure. Kidney International. 46:201-207, 1994. 68. Rogers, S.A., Rasmussen, J. Miller, S.B. and Hammerman, M.R. Effects of growth hormone on rat renal epidermal growth factor expression. Am. J. Physiol. 267:F208-F214, 1994. 69. Sorenson, C.M., Rogers, S.A., Korsmeyer, S.J. and Hammerman, M.R. Fulminant metanephric

apoptosis and abnormal kidney development in bcl-2-deficient mice. Am. J. Physiol. 268:F73-F81, 1995.


23

70. Rogers, S.A., Miller, S.B. and Hammerman, M.R. Triiodothyronine stimulates renal epidermal growth factor expression in adult rat Am. J. Physiol. 268:F128-F134, 1995. 71. Rogers, S.A., Miller, S.B., and Hammerman, M.R. Altered epidermal growth factor expression and thyroxine metabolism in kidneys following acute ischemic injury in rat Am. J. Physiol. 270:F21-F30, 1996. 72. Basile, D.P., Rovak, J.M., Martin, D.R., and Hammerman, M.R. Increased transforming growth

factor- 1 expression in regenerating rat renal tubules following ischemic injury. Am. J. Physiol. 270:F500-F509, 1996. 73. Padanilam, B.J., Martin, D.R., and Hammerman, M.R. Insulin-like growth factor I-enhanced renal expression of osteopontin following acute ischemic injury in rat. Endocrinology 137:2133- 2140, 1996. 74. Sorenson, C.M., Padanilam, B.J., and Hammerman, M.R. Abnormal postpartum renal development and cystogenesis in the bcl-2-/- mouse. Am. J. Physiol 271:F184-F193, 1996. 75. Sorenson, C.M., Padanilam, B.J., and Hammerman M.R. Abnormal renal development in the Os/+ mouse is intrinsic to the kidney. Am. J. Physiol 271:F234-F238, 1996. 76. Padanilam, B.J. and Hammerman, M.R. Ischemia-induced receptor for activated C kinase (RACK1) expression in rat kidneys. Am. J. Physiol. 272:F160-F166, 1997. 77. Franklin, S.C., Moulton, M., Sicard, G.A., Hammerman, M.R. and Miller, S.B., Insulin-like growth

factor I preserves renal function post-operatively. Am. J. Physiol. 272:F257-F259, 1997. 78. Rogers, S.A., Padanilam, B.J., Hruska K.A., Giachelli, C.M. and Hammerman, M.R., Metanephric osteopontin regulates nephrogenesis in vitro. Am. J. Physiol. 272:F469-F476, 1997. 79. Basile, D.P., Liapis, H. and Hammerman, M.R. Expression of bcl-2 and bax in regenerating rat

renal tubules following ischemic injury. Am. J. Physiol. 272:F640-F647, 1997. 80. Lewington, A.J.P., Padanilam, B.J. and Hammerman, M.R. Induction of calcyclin after ischemic injury to rat kidney. Am. J. Physiol. 273:F380-F385, 1997. 81. Emert, M.P., Sorenson, C.M., Basile, D.P., Rogers, J.G., Hammerman, M.R. and Billadello, J.J. The human plasminogen activator inhibitor type 1 gene promoter targets to kidney. Am. J. Physiol. 274:F405-F412, 1998. 82. Rogers, S.A., Lowell, J.A., Hammerman, N.A. and Hammerman, M.R. Transplantation of developing metanephroi into adult rats. Kidney International 54:27-37, 1998. 83. Padanilam, B.J., Lewington, A.J.P. and Hammerman, M.R. Expression of CD27 and ischemia/reperfusion-induced expression of its ligand Siva in rat kidneys. Kidney International 54:1967-1975, 1998.


24

84. Basile, D.P., Martin, D.R. and Hammerman, M.R. Extracellular matrix-related genes in kidney following ischemic injury: Potential role for TGF- in repair. Am. J. Physiol. 275: F894-F903, 1998.

85. Vijayan, A., Franklin, S.C., Behrend T., Hammerman, M.R. and Miller, S.B. Insulin-like growth

factor I improves renal function in patients with end-stage chronic renal failure. Am. J. Physiol. 276:R929-R934, 1999. 86. Rogers, S.A., Powell-Braxton, L., and Hammerman, M.R. Insulin-like growth factor I regulates renal development in rodents. Developmental Genetics 24:293-298, 1999. 87. Lewington, A.J.P., Padanilam, B.J., Martin, D.R., and Hammerman, M.R. Expression of CD44 in

kidney following acute ischemic injury in the rat. Am. J. Physiol. 278:R247-R254, 2000. 88. Martin, D.R., Lewington, A.J.P., Hammerman, M.R., and Padanilam, B.J. Inhibition of poly (ADP-

ribose) polymerase attenuates ischemic renal injury in rats. Am. J. Physiol. 279:R1834-R1840, 2000.

89. Rogers, S.A., Liapis, H. and Hammerman, M.R. Transplantation of metanephroi across the major

histocompatibility complex in rats. Am. J. Physiol. 280:R132-R136, 2001. 90. Rogers, S.A. and Hammerman, M.R. Transplantation of rat metanephroi into mice. Am. J.

Physiol. 280: R1865-R1869, 2001.

91. Rogers, S.A. and Hammerman, M.R. Transplantation of metanephroi after preservation in vitro. Am. J. Physiol. 281:R661-R665, 2001.

92. Akimoto, T, Liapis H. and Hammerman M.R. Microvessel formation from mouse embryonic aortic

explants is hypoxia and VEGF dependent Am. J. Physiol 283:R487-R495, 2002. 93. Rogers, S.A. Talcott, M. and Hammerman, M.R. Transplantation of pig metanephroi ASAIO

Journal 49:48-52, 2003.

94. Akimoto, T. and Hammerman M.R. Fibroblast growth factor 2 promotes microvessel formation from mouse embryonic aorta Am. J. Physiol 284:C378-C388, 2003.

95. Akimoto, T. and Hammerman, M.R. Microvessel formation from mouse aortic explants is

stimulated in vitro by secreted VEGF and extracts from metanephroi Am. J. Physiol 284:C1625-C1632, 2003.

96. Rogers, S.A. Liapis, H. and Hammerman M.R. Intraperitoneal transplantation of pancreatic

anlagen ASAIO Journal 49: 527-532, 2003. 97. Rogers, S.A., Chen F., Talcott M. and Hammerman M.R. Islet cell engraftment and control of

diabetes in rats following transplantation of pig pancreatic anlagen. Am. J. Physiol 286:E502-509, 2004.


25

98. Rogers, S.A. and Hammerman M.R. Prolongation of life in anephric rats following de novo renal organogenesis Organogenesis 1: 22-25, 2004.

99. Rogers, S.A., Droege D., Dusso A. and Hammerman M.R. Incubation of metanephroi with

vitamin D increases numbers of glomeruli Organogenesis 1:52-54, 2004. 100. Rogers, S.A., Liapis , H. and Hammerman M.R. Normalization of glucose post-transplantation

of pig pancreatic anlagen into non-immunosuppressed diabetic rats depends on obtaining anlagen prior to embryonic day 35. Transplant Immunology 14: 67-75, 2005.

101. Akimoto T, Hammerman M.R. and Kusano E. Low ambient O2 enhances ureteric bud branching

in vitro Organogenesis 2: 17-21, 2005.

102. Takeda S., Rogers SA., and Hammerman M.R. Differential origin for endothelial and mesangial cells after transplantation of pig fetal renal primordia into rat. Transplant Immunology 15:211-215, 2006.

103. Rogers SA, Chen F, Talcott M, Liapis H, and Hammerman M.R. .Glucose tolerance normalization

following transplantation of pig pancreatic primordia into non-immunosuppressed diabetic ZDF rats. Transplant Immunology 16:176-184, 2006. Erratum: 17:288-289, 2007.

104. Rogers SA., Chen F, Talcott MR, Faulkner C, Thomas JM, Thevis M, and Hammerman M.R.

Long-term engraftment following transplantation of pig pancreatic primordia into non-immunosuppressed diabetic rhesus macaques Xenotransplantation 14:591-602, 2007.

105. Rogers SA. and Hammerman M.R. Normalization of glucose post-transplantation into diabetic

rats of pig pancreatic primordia preserved in vitro Organogenesis 4: 48-51, 2008.

106. Rogers SA. Mohanakumar T, Liapis H and Hammerman M.R. Engraftment of cells from porcine islets of Langerhans and normalization of glucose tolerance following transplantation of pig pancreatic primordia in non-immune suppressed diabetic rats Am. J. Pathology 177:854-864, 2010. 107. Rogers SA, Tripathi Mohanakumar T, Liapis H, Chen F, Talcott MR, Faulkner C, and Hammerman M.R. Engraftment of cells from porcine islets of Langerhans following transplantation of pig pancreatic primordia in non-immune suppressed diabetic rhesus macaques Organogenesis 7: 154-162, 2011. 108. Hu L, Chen J, Yang X, Senpan A, Allen JS, Yanaba N, Caruthers SD, Lanza GM, Hammerman M.R., Wickline SA. Assessing intrarenal nonperfusion and vascular leakage in acute kidney injury with multinuclear 1 H/19 F MRI and perfluorocarbon nanoparticles. Magnetic Resonance in Medicine 71: 2186-2196, 2013.

http://www.ncbi.nlm.nih.gov/pubmed?term=Hu%20L%5BAuthor%5D&cauthor=true&cauthor_uid=23929727

http://www.ncbi.nlm.nih.gov/pubmed?term=Chen%20J%5BAuthor%5D&cauthor=true&cauthor_uid=23929727

http://www.ncbi.nlm.nih.gov/pubmed?term=Yang%20X%5BAuthor%5D&cauthor=true&cauthor_uid=23929727

http://www.ncbi.nlm.nih.gov/pubmed?term=Senpan%20A%5BAuthor%5D&cauthor=true&cauthor_uid=23929727

http://www.ncbi.nlm.nih.gov/pubmed?term=Allen%20JS%5BAuthor%5D&cauthor=true&cauthor_uid=23929727

http://www.ncbi.nlm.nih.gov/pubmed?term=Yanaba%20N%5BAuthor%5D&cauthor=true&cauthor_uid=23929727

http://www.ncbi.nlm.nih.gov/pubmed?term=Caruthers%20SD%5BAuthor%5D&cauthor=true&cauthor_uid=23929727

http://www.ncbi.nlm.nih.gov/pubmed?term=Lanza%20GM%5BAuthor%5D&cauthor=true&cauthor_uid=23929727

http://www.ncbi.nlm.nih.gov/pubmed?term=Hammerman%20MR%5BAuthor%5D&cauthor=true&cauthor_uid=23929727

http://www.ncbi.nlm.nih.gov/pubmed?term=Hammerman%20MR%5BAuthor%5D&cauthor=true&cauthor_uid=23929727

http://www.ncbi.nlm.nih.gov/pubmed?term=Wickline%20SA%5BAuthor%5D&cauthor=true&cauthor_uid=23929727


26

Editorials and Reviews: 1. Hammerman, M.R., and Schwab, S.J., Phosphate transport in the kidney, studies with isolated

membrane vesicles. Progress in Clinical and Biological Research 168: 325-330, 1984. 2. Hammerman, M.R. The interaction of insulin with the renal proximal tubular cell (Editorial

Review). Am. J. Physiol. 249:F1-F11, 1985. 3. Chesney, R.W., Mehls, O., Anast, C.S., Brown, F., Hammerman, M.R., Portals, A., Fallon, M.D.,

Mahan, J., Jr., and Alfrey, A.C. Renal Osteodystrophy in Children: The role of Vitamin D, Phosphorus, and parathyroid hormones. Am. J. Kidn. Diseases. 7: 275-284, 1986.

4. Hammerman, M.R. Phosphate transport across renal proximal tubular cell membranes (Editorial

review) Am. J. Physiol. 251:F385-F398, 1986. 5. Hammerman, M.R. Insulin-like growth factors and aging. Endocrine and Metabolism Clinics

of North America 16:995-1011, 1987. 6. Brenner, B.M., Schrier, R.W., Striker, G.F., Brown, D., Rabkin, R., Jamison, R.L., Hammerman,

M.R., Seifter, J.L., Daniel, T.O., Skorecki, K.L., and Fine, L. Forefronts in Nephrology, Hormone Receptor Interactions. Kidney International 32:S61-S67, 1987.

7. Klahr, S., Schrier, R.W., Haller, H., Stokes, J.B., Roth, J., Skorecki, K.L., Ives, H. E., Navar, L. G.,

Weinman, E. J., Birnbaumer, L., Ullrich, K. J., Hruska, K.A., and Hammerman, M.R. Forefronts in Nephrology, Calcium Signaling in Cells. Kidney International. 32:S77-S81, 1987.

8. Jamison, R.L., Hammerman, M.R., Kurokawa, K., Handler, J.S., Stokes, J.B. Brown, D., Schrier,

R.W., Brown, J., Ausiello, D.A., Dousa, T.P., Masur, S.K., and Goligorsky M.S. Forefronts in Nephrology, Membrane Traffic in MDCK Cells. Kidney International 32:S208-S210, 1987.

9. Hammerman, M.R. The growth hormone-insulin-like growth factor axis in kidney (Editorial

Review) Am. J. Physiol. 257:F503-F514, 1989. CORRIGENDA: 257: F1168, 1989. 10. Hammerman, M.R. The renal growth hormone-insulin-like growth factor I axis. Am. J. Kidney

Diseases. 17: 644-646, 1991. 11. Hammerman, M.R., and Miller, S.B. Renal cellular biology of growth hormone and insulin- like growth factor I. Pediatric Nephrology 5: 505-508, 1991. 12. Fine, L.G., Hammerman, M.R. and Abboud, H.E. Evolving role of growth factors in the renal response to acute and chronic disease. J. Am. Soc. Nephrol. 2:1163-1170, 1992. 13. Hammerman, M.R., Rogers, S.A. and Ryan, G. Growth factors and metanephrogenesis Am. J. Physiol. (Editorial Review) 262:F523-F532, 1992. 14. Hammerman, M.R., Actions of growth hormone in the kidney. J. Pediatric Endocrinology 5:15-22, 1992.


27

15. Hammerman, M.R., Ryan, G. and Miller, S.B. Expression of insulin-like growth factors in adult and embryonic kidney. Mineral and Electrolyte Metabolism 18:253-255, 1992. 16. Hammerman, M.R., O'Shea, M. and Miller, S.B. Role of growth factors in regulation of renal growth. Ann. Rev. Physiol. 55:305-321, 1993. 17. O'Shea, M., Miller, S.B., and Hammerman, M.R. Insulin-like growth factor I and the kidney Seminars in Nephrology 13:96-108, 1993. 18. O'Shea, M., Miller, S.B., Finkel, K., and Hammerman, M.R. Roles of growth hormone and growth factors in the pathogenesis and treatment of kidney disease. Current Opinion in Nephrology and Hypertension 2:67-72, 1993. 19. Hammerman, M.R. and Miller, S.B. The growth hormone-insulin-like growth factor axis in kidney revisited. Am. J. Physiol. (Editorial Review) 265: F1-F14, 1993. 20. Hammerman, M.R., Rogers, S.A., and Ryan, G. Growth factors and kidney development.

Pediatric Nephrology 7:616-620, 1993. 21. Hammerman, M.R. and Miller, S.B. Therapeutic use of growth factors in renal failure. J. Am. Soc. Nephrol. (Editorial Review) 5:1-11, 1994. 22. Hammerman, M.R., Ask the expert: What are the clinical uses of IGF I in acute and chronic renal failure? Pediatric Nephrology (Editorial) 8:544, 1994. 23. Hammerman, M.R. and Miller S.B. Growth factor gene expression in tubular epithelial injury. Current Opinion in Nephrology and Hypertension 4: 258-262, 1995. 24. Hammerman, M.R. Growth factors in renal development. Seminars in Nephrology 15: 291- 299, 1995. 25. Hammerman, M.R. and Miller, S.B. The role of growth factors in preventing acute renal failure.

Seminars in Dialysis 9:464-468, 1996. 26. Goodyer, P and Hammerman M. Renal Development and growth factors. Proceedings of the Sixth International Workshop on Developmental Nephrology. Pediatric Nephrology 10:827- 828, 1996. 27. Hammerman, M.R. New treatments for acute renal failure: Growth Factors and Beyond. Current Opinion in Nephrology and Hypertension (Editorial) 6:7-9, 1997. 28. DuBose, T.D., Warnock, D.G., Mehta, R.L., Bonventre, J.V., Hammerman, M.R., Molitoris,

B.A., Paller, M.S., Seigel, N.J., Scherbenske, M.J. and Striker, G.E. Acute Renal Failure in the 21st Century. Recommendations for Management and Outcomes Assessment. Am. J. Kidn. Diseases 29:793-799, 1997.

29. Hammerman, M.R and Miller, S.B. The effects of GH and IGF I on renal growth and function J. of Pediatrics 131:S17-S19, 1997.


28

30. Hammerman, M.R. Renal programmed cell death and the treatment of renal disease. Current Opinion in Nephrology and Hypertension (Editorial) 7:1-3,1998. 31. Basile, D.P. and Hammerman, M.R. TGF- in renal development and renal growth Mineral and Electrolyte Metabolism 24:144-148, 1998. 32. Hammerman, M.R. Potential role of growth factors in the prophylaxis and treatment of acute renal failure. Kidney International 53:S19-S22, 1998. 33. Hammerman, M.R. Growth factors and apoptosis in acute renal injury. Current Opinion in Nephrology and Hypertension 7:419-424, 1998. 34. Hammerman, M.R. Regulation of cell survival during renal development. Pediatric Nephrology 12:596-602, 1998 . 35. Hammerman, M.R. Developmental nephrology comes of age. Current Opinion in Nephrology and Hypertension (Editorial) 8:7-8, 1999. 36. Hammerman, M.R. Distinguished Lecturers Series: New developments in kidney development. Nephron 81:131-135, 1999. 37. Hammerman, M.R., The growth hormone insulin-like growth factor axis in kidney re-revisited.

Nephrology, Dialysis Transplantation 14:1853-1860, 1999. 38. Hammerman, M.R. Insulin-like growth factor I treatment for end-stage renal disease at the

millennium. Current Opinion in Nephrology and Hypertension (Editorial) 9:1-3, 2000.

39. Hammerman, M.R., Recapitulation of phylogeny by ontogeny in nephrology. (Nephrology Forum) Kidney International 57:742-755, 2000.

40. Hammerman, M.R. Transplantation of renal precursor cells: a new therapeutic approach.

Pediatric Nephrology 14: 513-517, 2000.

41. Hammerman, M.R. Safirstein, R., Harris, R.C., Toback, F.G. and Humes, H.D. Acute Renal Failure Part III. Role of growth factors in the process of renal regeneration and repair. Am. J. Physiol. 279:F3-F11, 2000.

42. Hammerman, M.R. In pursuit of novel therapies based on an understanding of renal growth.

Am. J. Kidney Diseases 36: lxx-lxxii, 2000. 43. Hammerman, M.R. Growing Kidneys. Current Opinion in Nephrology and Hypertension 10:13-17, 2001. 44. Hammerman, M.R. Xenotransplantation of renal primordia. Current Opinion in Nephrology and

Hypertension 11:11-16, 2002.


29

45. Hammerman, M.R. Transplantation of developing. kidneys Transplantation Reviews 16:62-71, 2002.

46. Hammerman, M.R. Xenotransplantation of developing kidneys Am. J. Physiol 283:F601- F606, 2002. 47. Hammerman, M.R. Transplantation of embryonic kidneys. Clinical Science 103: 599-612, 2002. 48. Hammerman M.R. Applications of cell therapy to whole kidney replacement. Current Opinion in Nephrology and Hypertension 12:1-4, 2003. 49. Hammerman M.R. Therapeutic promise of embryonic kidney transplantation. Nephron 93:e58-

e62 2003. 50. Hammerman, M.R. Tissue engineering the kidney. Kidney International. 63:1195-1204, 2003. 51. Hammerman, M.R. Applications of Organ Precursor Cell Therapy: Can lessons from embryonic

kidney transplantation be applied to the endocrine pancreas? Current Opinion in Nephrology and Hypertension 13:23-29, 2004.

52. Hammerman M.R. Transplantation of embryonic organs – kidney and pancreas. Am. J.

Transplantation 4(supplement 6): 14-24, 2004. 53. Hammerman, M.R. and Cortesini, R. Organogenesis and Tissue Engineering. Transplant

Immunology 12:191-192, 2004. 54. Hammerman M.R. Treatment for End-stage Renal Disease: An organogenesis/tissue engineering Odyssey. Transplant Immunology 12:211-218, 2004. 55. Hammerman M.R. Organogenesis of kidneys following transplantation of renal progenitor cells Transplant Immunology 12:229-239, 2004. 56. Hammerman M.R. Organogenesis of endocrine pancreas from transplanted embryonic anlagen Transplant Immunology 12:249-258, 2004.

57. Hammerman M.R. Renal Organogenesis from Transplanted Metanephric Primordia

J. Am. Soc. Nephrol. 15: 1126-1132, 2004. 58. Hammerman M.R. Pancreas and Kidney Transplantation using Embryonic Donor Organs

Organogenesis 1: 3-13, 2004. 59. Hammerman M.R. Growing new kidneys in situ. Clinical and Experimental Nephrology 28:

169-177, 2004. 60. Hammerman M.R. Cellular Transplantation of Nephrons Kidney International 67:1677-1679,

2005. 61. Hammerman M.R. Organogenesis of the Endocrine Pancreas Kidney International 68:1953-

1955, 2005.


30

62. Hammerman M.R. Windows of opportunity for organogenesis Transplant Immunology 15:1-8,

2005. 63. Hammerman M.R. Strategies for cell replacement for kidney failure Expert Opinion on

Biological Therapy 6:87-97, 2006. 64. Hammerman M.R. Growing New Endocrine Pancreas in Situ Clinical and Experimental

Nephrology 10:1-7, 2006. 65. Hammerman M.R. Transplantation of renal primordia: Renal organogenesis Pediatric

Nephrology 22:1991-1998, 2007. 66. Hammerman M.R. Transplantation of kidney and endocrine pancreas: The window opens

Organogenesis 3:59-66, 2007. 67. Hammerman M.R. Xenotransplantation of pancreatic and kidney primordia: Where do we stand?

Transplant Immunology 21:93-100, 2009. 68. Hammerman M.R. Organogenetic Tolerance Organogenesis 6:270-275, 2010. 69. Hammerman M.R. Xenotransplantation of embryonic pig kidney or pancreas to replace the

function of mature organs. J. Transplantation Article ID 501749, 2011. 70. Hammerman M.R. Engraftment of insulin-producing cells from porcine islets in non-immune

suppressed rats or non-human primates transplanted previously with embryonic pig pancreas J. Transplantation Article ID 261352. 2011.

71. Hammerman M.R. Development of a novel xenotransplantation strategy for treatment of diabetes mellitus in rat hosts and translation to non-human primates. Organogenesis 8:41-48 2012.

72. Hammerman M.R. Xenotransplantation of embryonic pancreas for treatment of diabetes mellitus in non-human primates J. Biomedical Science and Engineering 6: 6-11 2013. 73. Hammerman M.R. Underpinnings of cellular organ replacement therapies Current Opinion in

Organ Transplantation 19:131-133, 2014. 74. Hammerman M.R. Classic and Current Opinion in embryonic organ transplantation Current

Opinion in Organ Transplantation 19:133-139, 2014. 74. Hammerman M.R. Generation and use of renal cells for replacement therapies Current Opinion

in Organ Transplantation 20:159, 2015..


31

Book Chapters: 1. Hammerman, M.R. Thyroid Disease. In Manual of Medical Therapeutics, 23rd Edition, Miller,

L. and Freitag, J., eds. Little Brown and Company, Boston, 1980. pp. 323-336. 2. Klahr, S., Hammerman, M.R., Martin, K., and Slatopolsky, E. Renal effects of parathyroid

hormone and calcitonin, In Renal Endocrinology, Dunn, M.J., ed., Williams and Wilkins, Baltimore, pp. 269-322, 1983.

3. Hammerman, M.R. Thyroid Disease. In Manual of Medical Therapeutics, 24th Edition, Frisse,

M. and Campbell, W., eds. Little Brown and Company, Boston, 1983, pp. 309-322. 4. Hammerman, M.R., Klahr, S., and Cohn, D.E. Regulation of Na+/H+ Antiporter in Renal Brush

border vesicles: Effects of chronic renal failure, metabolic acidosis and parathyroidectomy, In Hydrogen Ion Transport in Epithelia, Forte, J.G., and Rector, F.C., eds., Wiley and Sons, Inc., New York, pp. 139-146, 1984.

5. Klahr, S., and Hammerman, M.R. Renal Metabolism, In The Kidney: Physiology and

Pathophysiology. Seldin, D.W., and Giebisch, G., eds., Raven Press, New York, pp. 699-718, 1985.

6. Rotwein, P., DeVol, D., Lajara, R., Bechtel, P., and Hammerman, M.R. Physiological Regulation

of Insulin-like Growth Factor Expression, In Molecular and Cellular Biology of Insulin-like Growth Factors and Their Receptors, LeRoith, D., and Raizada, M.K., eds., Plenum, New York, 1989.

7. Hammerman, M.R., and Miller, S.B. Growth hormone, insulin-like growth factor I and kidney. In

Nephrology: Proceedings of the XIth International Congress of Nephrology Hatano, M. ed. Springer-Verlag, Tokyo. Vol II pp. 1304-1310, 1991. 8. Klahr, S., Hamm, L.L., Hammerman, M.R., and Mandel, L.J. Renal metabolism: integrated

responses, In Handbook of Physiology, Renal Physiology, Giebisch, G., and Windhager, E., eds. Oxford University Press, New York. pp. 2263-2234, 1992.

9. Hammerman, M.R., and Miller, S.B. Insulin-like growth factors in mature and developing kidney,

In Molecular Biology of the Kidney in Health and Disease, Bonventre, J.V., and Schlondorff, D., eds. Marcel Dekker. New York, New York. pp. 561-572, 1995.

10. Hammerman, M.R. and Miller, S.B. IGF I and acute renal failure, In Acute Renal Failure: Emerging New Concepts and Therapeutic Strategies, Goligorsky, M.S. ed. Churchill Livingstone, New York, New York. Pp. 425-438, 1995. 11. Goligorsky, M.S., Allgren, R., Ohlstein, E. and Hammerman, M. Medical management of ischemic

acute tubular necrosis. In Current Therapy in Nephrology and Hypertension. A Companion to Brenner and Rector’s The Kidney. B.M. Brenner, H. Brady and C. Wilcox eds. W.B. Saunders, Philadelphia PA pp. 21-28, 1998.


32

12. Hammerman M.R. Implantation of renal rudiments In Future Strategies for Organ Replacement. J. Polak, L Hench and P. Kemp eds. Imperial College Press. London UK, Pp199-211, 2002.

13. Hammerman M.R. Transplantation of Renal Anlagen In Recent Research Developments in

Physiology S.J. Pandalai ed. Research Signpost Kerala India Pp 429-443, 2003.

14. Hammerman M.R. Strategies for Cell Replacement for Kidney Failure In Cellular Transplantation: From Lab to Clinic P. Carpenter C. Halberstadt eds. Elsevier San Diego Pp. 153-166, 2007.

15. Hammerman M.R. Chapter 68, Renal Tissue Engineering and Regeneration In Brenner & Rector’s The Kidney 8th Edition B. M. Brenner ed. Elsevier San Diego Pp 2199-2214, 2007.

16. Hammerman M.R. Tissue engineering applications in endocrinology: Organogenesis of the

endocrine pancreas In Fundamentals of Tissue Engineering and Regenerative Medicine U. Meyer and H.P. Wiesmann eds. Springer, Berlin Pp 939-950, 2009.

17. Hammerman M.R. Renal Organogenesis: Growing a replacement kidney in situ from transplanted

renal primordia In Regenerative Nephrology M. S. Goligorsky ed Elsevier San Diego Pp 19-36, 2011.

18. Hammerman M.R. Frontiers in the Field of Transplantation: Organogenesis In Pathology of

Solid Organ Transplantation H. Liapis, and H. Wang eds Springer Berlin Pp 57-74, 2011. 19. Hammerman M.R. Xenotransplantation in the kidney: an historical perspective In Kidney

Development Repair and Regeneration M. Little ed Elsevier, San Diego Pp 507-520, 2015.


33

Clinical Publications: 1. Hammerman, M.R. The intern becomes an iron man. In St. Louis Post Dispatch. 97:98:5D, 1975. 2. Cryer, P., Sagel, S., Aach, R., Baenziger, J., Hammerman, M., and Perkoff, G. Primary

amenorrhea in an elderly woman. Am. J. Med. 65:514-520, 1978. 3. Klahr, S., Hoffsten, P., Aronberg, D., Meyer, J., and Hammerman M. Recurrent hematuria with

late hypertension and renal failure Am. J. Med. 65:679-690, 1978. 4. Slatopolsky, E., McLennan, B., Chaplin, H., Prioleau, P., and Hammerman, M. Erythrocytosis Am. J. Med. 65:1006-1014, 1978. 5. Peck, W., Jost, G., Hammerman M., and Bauer, W., Slatopolsky, E., and Cryer, P. Osteopenia,

hypercalcemia and an anterior cervical mass. Am. J. Med. 66: 133-140, 1979. 6. Hammerman, M.R., Clutter, W., Meltzer, V., Levitt, R., and Bobzein, B. Persistent hypertension

following resection of pheochromocytoma. Am. J. Med. 73:97-104, 1982. 7. Hammerman, M.R., Bowen, W.G., and Janney, C. Hypercalcemia and chest pain in a 48 year old

male. Am. J. Med. 75:337-344, 1983. 8. Hammerman, M.R., Hodges, F.J., Strickler, R., and McKeel, D. Primary Hypothyroidism and

hypopituitarism in a young woman. Am. J. Med. 77:319-330, 1984. 9. Klahr, S., Kissane, J., Aronberg, D., de Marcheno, O., and Hammerman, M.R., Cerebellar

Dysfunction and Nephrotic Syndrome in a 50-year old man. Am J. Med. 79:621-628, 1985. 10. Hammerman, M.R., Sagel, S., Jaffe, A., and Becich, M., Atrial Fibrillation, Refractory

Hypotension, and Death in a 70-year Old Woman. Am. J. Med. 85:227-234, 1988. 11. Hammerman, M.R., Lee, J.K.T., Clutter, W., and Williamson, J.R., Hypercalcitoninemia and

adrenal mass in a woman with MEN Type IIA. Am J. Med. 90:243-250, 1990. 12. Hammerman, M.R., Solomon, S. and McKeel, D. Hypothyroidism and enlarging thyroid mass in

a young woman. Am. J. Med. 95:534-541, 1993. 13. Hammerman, M.R., Gutierrez, F., and Huettner, P. Acute renal failure and rash in an elderly

woman. Am. J. Med. 97:93-100, 1994. 14. Hammerman, M.R., Sloan, R. and Hill, A. Nephrotic syndrome, nephromegaly, renal hyperfiltration and sudden death in a diabetic woman. Am. J. Med. 99:563-572,1995.


34

Patents: 1. Method of Administration of IGF I: USA # 5,565, 428 (10-15-96) 2. Method of Administration of IGF I: USA # 5,741,776 (4-21-98) 3. Chimeric Kidney: USA # 5,976, 524 (11-2-99) Use and preparation of non-human embryonic metanephric tissue EPO853942 (8-24-05) 4. Composition and Method for Improving Function of Embryonic Kidney Transplants: USA # 7,074,762 (7-11-06); Singapore #81766 (8-29-03); Australia # 774697 (10-14-04) 5. Method of Preserving Metanephroi in Vitro Prior to Transplantation Australia # 798,790 (12-1-05) 6. Chimeric Pancreas USA # 7,384,630 (6-10-08); Australia #2003259298 (8-31-06) Canada #2,477,538 (6-27-07). 7. Inducement of Organogenetic Tolerance for Pancreas Xenotransplant USA # 8,709,400 (4-29-14)

mrh cv jan 31 2016

Documents